Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
March 16, 2021
Patent Application Number
16308007
Date Filed
June 13, 2017
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present disclosure relates to the treatment of muscle conditions, such as SMA, with the use of an agent that inhibits myostatin signaling. The disclosure includes combination therapies that include a myostatin inhibitor and a neuronal corrector.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.